Lack of tolerable treatment options for patients with schizophrenia.
about
Schizophrenia relapse, patient considerations, and potential role of lurasidonePharmacokinetics and Pharmacodynamics of Lurasidone Hydrochloride, a Second-Generation Antipsychotic: A Systematic Review of the Published Literature.Initial Clinical Experience of RP5063 Following Single Doses in Normal Healthy Volunteers and Multiple Doses in Patients with Stable Schizophrenia.A systematic literature review of the clinical and health economic burden of schizophrenia in privately insured patients in the United States.Cariprazine for acute and maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy
P2860
Lack of tolerable treatment options for patients with schizophrenia.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lack of tolerable treatment options for patients with schizophrenia.
@en
Lack of tolerable treatment options for patients with schizophrenia.
@nl
type
label
Lack of tolerable treatment options for patients with schizophrenia.
@en
Lack of tolerable treatment options for patients with schizophrenia.
@nl
prefLabel
Lack of tolerable treatment options for patients with schizophrenia.
@en
Lack of tolerable treatment options for patients with schizophrenia.
@nl
P2093
P2860
P356
P1476
Lack of tolerable treatment options for patients with schizophrenia.
@en
P2093
Alice Guiraud-Diawara
Anna Eramo
Clement Francois
Holly B Krasa
Patricia Rohman
Ruth Duffy
Siddhesh A Kamat
Stephen S Johnston
Steve J Offord
Susan N Legacy
P2860
P304
P356
10.2147/NDT.S91917
P407
P577
2015-12-16T00:00:00Z